Any questions? Contact us+49 761-389 49-0

Seraseq® Homologous Recombinant Deficiency (HRD) Reference Materials

Seraseq® Homologous Recombinant Deficiency (HRD) Reference Materials

Seraseq® Homologous Recombinant Deficiency (HRD) Reference Materials

#0710-2643

SeraCare has developed contrived tumor-normal cell line-derived HRD reference materials to support the development, validation, and routine determination of HRD status in cancer patients.

€814.00 *

Prices plus VAT plus shipping costs

Delivery time 7 Workdays

Size: 1 x 10 µm
  • 0710-2643
Genomic scars introduced by homologous recombination DNA repair deficiency (HRD) are response... more

Genomic scars introduced by homologous recombination DNA repair deficiency (HRD) are response biomarkers for effective PARP inhibitor therapy. HRD measurements have the potential to improve cancer therapy as evidenced by over 100 clinical trials that include HRD today, however standardizing and democratizing HRD measurements remain a challenge.

 Features:

- Derived from tumor and matched-normal cell lines
- ~65% tumor fraction blend
- 10 μm-curls, DNA-Ausbeute >100 ng pro curl

 - FFPE format (3 products):

* Seraseq® FFPE HRD High-Positive (GIS 72 ±3)+
* Seraseq® FFPE HRD Low-Positive (GIS 54 ± 2)
* Seraseq® FFPE HRD Negative (GIS 31 ± 2)+


For additional information about the product, please visit the manufacturer's website.
PROPERTIES
storage temperature: 2-8°
shipping method: blue ice packs
regulatory status: RUO
Top-Seller
Top-Seller
Tipp
Top-Seller
Viewed